| 186.18 2.07 (1.12%) | 01-09 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |   |
|||
| Targets | 6-month : | 225.5 | 1-year : | 263.39 |
| Resists | First : | 193.07 | Second : | 225.5 |
| Pivot price | 173.15 |
|||
| Supports | First : | 155.58 |
Second : | 132.41 |
| MAs | MA(5) : | 177.59 |
MA(20) : | 173.96 |
| MA(100) : | 122.92 |
MA(250) : | 106.15 |
|
| MACD | MACD : | 8.4 |
Signal : | 8.9  |
| %K %D | K(14,3) : | 77.7 |
D(3) : | 66.9 |
| RSI | RSI(14): 59.5 |
|||
| 52-week | High : | 193.07 | Low : | 28.81 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ NUTX ] has closed below upper band by 16.2%. Bollinger Bands are 1.2% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 192.12 - 192.68 | 192.68 - 193.32 |
| Low: | 181.31 - 181.98 | 181.98 - 182.74 |
| Close: | 184.98 - 186.01 | 186.01 - 187.16 |
Nutex Health, Inc. operates as a technology-enabled healthcare services company. It operates through two divisions: Hospital division and Population Health Management division. The Hospital division implements and operates health care models, including micro-hospitals, specialty hospitals, and hospital outpatient departments. This division owns and operates 21 facilities in 8 states. The Population Health Management division owns and operates provider networks, such as independent physician associations. Its management services organizations provide management, administrative, and other support services to its affiliated hospitals and physician groups. This division's cloud-based proprietary technology platform aggregates data across multiple information systems, settings, and sources to create a holistic view of each patient and provider, as well as allows to deliver care. The company is based in Houston, Texas.
Fri, 09 Jan 2026
Is Nutex Health’s (NUTX) J.P. Morgan Debut Reframing Its Physician-Led Model’s Investment Narrative? - Sahm
Thu, 08 Jan 2026
Is Nutex Health’s (NUTX) J.P. Morgan Debut Reframing Its Physician-Led Model’s Investment Narrative? - simplywall.st
Wed, 07 Jan 2026
Assessing Nutex Health (NUTX) Valuation As Conference Spotlight Draws Fresh Investor Attention - Sahm
Mon, 05 Jan 2026
NUTEX HEALTH TO ATTEND AND PRESENT AT THE 2026 J.P. MORGAN HEALTHCARE CONFERENCE IN JANUARY IN SAN FRANCISCO - Yahoo Finance
Sat, 03 Jan 2026
Nutex: Stellar Growth But Sustainability Doubts Linger - Seeking Alpha
Tue, 16 Dec 2025
Nutex Health (NASDAQ:NUTX) Trading Down 7.3% - Time to Sell? - MarketBeat
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Healthcare Information Services
|
|
| Shares Out | 7 (M) |
| Shares Float | 5 (M) |
| Held by Insiders | 28.1 (%) |
| Held by Institutions | 35.1 (%) |
| Shares Short | 817 (K) |
| Shares Short P.Month | 806 (K) |
| EPS | 20.48 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 45.93 |
| Profit Margin | 12.2 % |
| Operating Margin | 48.6 % |
| Return on Assets (ttm) | 31.9 % |
| Return on Equity (ttm) | 101.6 % |
| Qtrly Rev. Growth | 239.8 % |
| Gross Profit (p.s.) | 79.26 |
| Sales Per Share | 138.78 |
| EBITDA (p.s.) | 53.69 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 178 (M) |
| Levered Free Cash Flow | 116 (M) |
| PE Ratio | 9.08 |
| PEG Ratio | 0 |
| Price to Book value | 4.05 |
| Price to Sales | 1.34 |
| Price to Cash Flow | 7.4 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|